Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/1994
1.
Phase III Randomized, Double-Blind Study of Macrophage Colony-Stimulating Factor vs Placebo, Each with Standard Amphotericin-B Therapy, in Cancer Patients with Definitive or Probable Invasive Candidiasis (Summary Last Modified 06/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
3 and over
EORTC-19922
Last Modified:
12/1/1989
2.
Phase I/II Evaluation of Macrophage Colony Stimulating Factor in Patients with Advanced Cancer (Summary Last Modified 12/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
any age
NCI
NCI-89-C-167A
NCI-T89-0082N, T89-0082
Last Modified:
11/1/1994
3.
Phase II Study of Intravenous M-CSF Administered for Four 7-Day Courses for non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia in First, Second, or Third Relapse (Summary Last Modified 11/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
GENE-C9202-04
NCI-V94-0410
Last Modified:
12/1/1992
4.
Phase II Trial of Murine Monoclonal Antibody D6.12 plus M-CSF in Patients with Advanced Colorectal or Gastric Carcinoma (Summary Last Modified 12/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
UAC-2129
NCI-B92-0003, B92-0003
Last Modified:
8/1/1991
5.
Phase IA/IB Study of rM-CSF in Patients with Cancer (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
CCF-RPC-3272A
NCI-B90-0001, B90-0001
Last Modified:
6/1/1991
6.
Phase I Study of M-CSF in Patients with Myelodysplastic Syndrome (Summary Last Modified 06/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
AECM-9006164
NCI-V90-0128
Last Modified:
11/1/1990
7.
Phase I Study of Recombinant Human M-CSF in Patients with Acute Myelogenous Leukemia (Summary Last Modified 11/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
AECM-9006166
NCI-V90-0129
Last Modified:
4/1/1991
8.
Phase I Study of M-CSF in Pediatric Patients with Refractory Neuroblastoma, Osteosarcoma, and Other GD2- and GD3-Positive Tumors (Summary Last Modified 04/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
child
MSKCC-90114
NCI-V91-0010
Last Modified:
9/1/1992
9.
Phase I Study of M-CSF/IFN-G in Patients with Advanced Malignancies (Summary Last Modified 09/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
FCCC-90073
NCI-T90-0157D, T90-0157
Last Modified:
6/1/1992
10.
Phase I Study of MOAB R24/M-CSF in Patients with Advanced Melanoma (Summary Last Modified 06/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
over 18
MSKCC-91017
NCI-B90-0015, B90-0015
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute